Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.75
+0.82 (11.83%)
At close: Feb 6, 2026, 4:00 PM EST
7.77
+0.02 (0.26%)
After-hours: Feb 6, 2026, 6:54 PM EST

Replimune Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
6407515021,0018021,419
Market Cap Growth
-36.13%49.72%-49.87%24.82%-43.49%288.25%
Enterprise Value
447290111445414959
Last Close Price
7.759.758.1717.6616.9830.51
PB Ratio
2.931.811.341.801.952.84
P/TBV Ratio
3.041.811.341.801.952.84
Debt / Equity Ratio
0.360.180.200.110.080.07
Quick Ratio
5.437.8210.5317.3319.3133.03
Current Ratio
5.607.9510.7217.5219.4633.25
Return on Equity (ROE)
-90.88%-62.58%-46.42%-36.06%-25.94%-23.70%
Return on Assets (ROA)
-43.24%-31.26%-25.66%-19.65%-14.33%-12.41%
Return on Capital Employed (ROCE)
-114.40%-53.10%-52.10%-28.40%-26.10%-14.60%
Earnings Yield
-49.20%-32.93%-43.03%-17.42%-14.73%-5.70%
FCF Yield
-44.26%-26.49%-38.11%-13.03%-10.54%-4.50%
Buyback Yield / Dilution
-22.99%-21.02%-14.36%-11.49%-12.89%-34.99%
Updated Feb 3, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q